MUN91789
编号: 21245
Cas号: 2144491-78-9
纯度: 98% Min.
MUN91789, also known as CPD77, is a potent inhibitor of SARS-CoV-2 main protease. MUN91789 may serve as good scaffolds for the design of novel antiviral agents able to target the active site of SARS-CoV-2 MPro. This product has not formal name. For the convenience of scientific communication, we named it by combining its Inchi key (3 letters from the first letter of each section) with the last 5 digits of its CAS number (see MedKoo Chemical Nomenclature, https://www.medkoo.com/page/naming).
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | MUN91789 |
|---|---|
| Iupac 化学名称 | N-(4-(tert-butyl)phenyl)-N-(2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl)-1H-imidazole-5-carboxamide |
| 同义词 | CPD77; CPD-77; CPD 77; MUN91789; MUN-91789; MUN 91789; |
| 英文同义词 | CPD77; CPD-77; CPD 77; MUN91789; MUN-91789; MUN 91789; |
| 分子式 | C27H33N5O2 |
| 分子量 | 459.594 |
| Smile | O=C(NC1CCCCC1)C(N(C2=CC=C(C(C)(C)C)C=C2)C(C3=CN=CN3)=O)C4=CC=CN=C4 |
| InChiKey | MUNFBYOTGGMQOS-UHFFFAOYSA-N |
| InChi | InChI=1S/C27H33N5O2/c1-27(2,3)20-11-13-22(14-12-20)32(26(34)23-17-29-18-30-23)24(19-8-7-15-28-16-19)25(33)31-21-9-5-4-6-10-21/h7-8,11-18,21,24H,4-6,9-10H2,1-3H3,(H,29,30)(H,31,33) |
| Cas号 | 2144491-78-9 |
| 相关CAS号 | N-(4-(tert-butyl)phenyl)-N-(2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl)-1H-imidazole-5-carboxamide |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
| 外观性状 | Solid powder |
|---|---|
| 纯度 | 98% Min. |
| 存储 | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| 海关编码 |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Andrianov, Alexander M.; Kornoushenko, Yuri V.; Karpenko, Anna D.; Bosko, Ivan P.; Tuzikov, Alexander V. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease. ChemRxiv. 2020, Pages1-21。
